(AP) High rates of the most effective type of malaria-fighting drugs sold in three African countries are poor quality — including nearly half the pills sampled in Senegal — raising fears of increased drug resistance that could wipe out the last weapon left to battle a disease that kills 1 million people each year, according to a U.S. report released Monday.
Between 16 percent and 40 percent of artemisinin-based drugs sold in Senegal, Madagascar and Uganda failed quality testing, including having impurities or not containing enough active ingredient, the survey found (more…)
Sphere: Related Content
